Peptide Payments and Fentanyl Precursors: A Growing Crypto AML Problem
Research published by TRM Labs in October 2026 reveals that Americans buying grey-market peptides — compounds marketed for weight loss, muscle recovery, and tanning — are in many cases sending cryptocurrency to the same Chinese chemical manufacturers that the US Department of Justice and Treasury Department have identified as suppliers of fentanyl precursors. Crypto inflows to these vendors climbed 32% between 2023 and 2025, and payments have largely migrated from Bitcoin to USDT on the TRON network. For compliance officers, auditors, and CFOs at virtual asset service providers, this is a live screening problem, not a distant policy concern.
The Overlap Between Peptides and Fentanyl Precursor Vendors
The grey market for peptides has expanded sharply alongside demand for GLP-1 weight-loss therapies. With brand-name versions costing well over USD 1,000 a month, a significant number of consumers have turned to unregulated suppliers that sell the same active ingredients without a prescription. Most of the raw powder feeding that market is manufactured in China, and many of those Chinese producers are long-established chemical companies that have simultaneously supplied fentanyl precursors to drug trafficking organisations.
What the vendor catalogs show
TRM Labs identified over 150 unique Chinese chemical manufacturers accepting cryptocurrency payments as of Q3 2026. Roughly 75% of those vendors list both fentanyl precursors and peptides on their websites. That figure is likely understated: following a wave of US sanctions and indictments, several sellers have removed fentanyl-class listings from public-facing pages and now quote those products only through private channels. On many storefronts, peptide products occupy the homepage while precursor chemicals sit on pages that are reachable only through a direct URL, deliberately excluded from navigation menus.
One indicted firm, Anhui Rencheng Technology, illustrates the pattern clearly. The DOJ charged it in the Eastern District of New York in June 2023 with conspiring to manufacture and distribute fentanyl. As of September 2026, its website continued to list the peptide Melanotan II and semaglutide alongside fentanyl-class chemicals including the precursor 1-Boc-4-piperidone. The same site claimed warehouse locations in the United States, Canada, Germany, and Mexico.
Treasury and DOJ actions already on the record
The US government's response has been building for several years. The DOJ brought its first charges against a China-based chemical maker for trafficking fentanyl precursors in June 2023. The Treasury Department's Office of Foreign Assets Control subsequently sanctioned Guangzhou Tengyue in 2025, noting publicly that the firm's advertised catalog spanned fentanyl and amphetamine precursors as well as peptides. A separate action charged Chinese fentanyl suppliers with terrorism financing, extending the legal exposure these vendors face. Despite these measures, TRM's data shows that crypto inflows to the affected vendor category continued to grow through 2025.
Crypto Payment Flows: The Data Behind the 32% Rise
TRM Labs tracked cryptocurrency inflows to vendors confirmed to be selling both peptides and fentanyl precursors across three years. The figures are striking.
| Year | Crypto Inflows (USD) |
|---|---|
| 2023 | 28.2 million |
| 2024 | 33.8 million |
| 2025 | 37.3 million |
The aggregate rise of approximately 32% occurred against a backdrop of active US law enforcement and parallel enforcement by Chinese authorities, which makes the sustained growth in inflows more significant, not less.
The shift to USDT on TRON
Across the same period, the dominant payment asset shifted away from Bitcoin. USDT on the TRON network now accounts for the majority of payments to these vendors. TRM has documented this migration across illicit volume more broadly: stablecoin rails offer fast, cheap settlement, and the pseudonymity characteristics of TRON-based USDT have attracted actors seeking to reduce on-chain traceability. For compliance teams, this means that screening programs focused narrowly on Bitcoin flows will miss a growing share of this activity.
Buyer geography: the US leads
Attributing on-chain transactions to a specific country is inherently limited, because most payments route through global exchanges that cannot be pinned to a single jurisdiction. TRM addressed this by analysing the subset of payments routed through single-country cryptocurrency exchanges, combined with findings from its own investigations. Within that identifiable slice:
- The United States accounts for approximately 57% of value sent to vendors confirmed to list both product types.
- Australia follows at around 25%.
- Thailand accounts for roughly 10%.
US payments in this traceable subset arrive predominantly through consumer-facing crypto payment applications rather than traditional exchanges, consistent with retail buyers rather than institutional actors. This detail matters for compliance teams: the risk is distributed across retail-facing on-ramps, not concentrated in a handful of large corporate accounts.
AML and Compliance Implications for Firms
The TRM findings create concrete obligations and risks for several categories of institutions. For teams looking for a broader framework on red-flag typologies, our analysis of AML red flags compliance teams must know from crypto bridge hacks provides a useful parallel on how illicit actors exploit infrastructure gaps, and the question of scale is addressed in our coverage of how AI is being used to detect Bitcoin money laundering at scale.
Virtual asset service providers and exchanges
Any VASP with US customers, or with customers in Australia or Thailand given the geography data above, should treat payments to the identified vendor category as a material risk. The Bank Secrecy Act requires VASPs registered with FinCEN to file Suspicious Activity Reports when they know, suspect, or have reason to suspect that a transaction involves funds from an illegal activity or is designed to evade reporting requirements. Payments to sanctioned entities such as Guangzhou Tengyue would independently trigger OFAC obligations. Because the dominant rail is now USDT on TRON, screening must cover stablecoin addresses and not just Bitcoin wallet clusters.
Consumer payment apps that support crypto transfers face a particular challenge. TRM's data specifically identifies these apps as a primary on-ramp for US buyers in the identifiable slice. That places a due diligence burden on platforms that may have historically treated low-value retail transfers as lower risk.
Accounting firms and CFOs handling crypto clients
For accounting firms running crypto bookkeeping software or digital asset accounting software on behalf of clients, the compliance dimension here is not limited to the payment platforms themselves. If a client's treasury or payment operations involve TRON-based USDT flows, particularly to counterparties in China or through wallets linked to chemical vendors, the firm's own AML obligations under its professional body's guidance and, where applicable, the BSA may be engaged. Know-your-customer procedures should be reviewed for clients operating in the peptide or dietary supplement supply chain, given the vendor overlap TRM has documented.
Auditors signing off on financial statements that include cryptocurrency assets should also consider whether management has adequate controls to detect vendor-side sanctions exposure. An entity that unknowingly receives payments from a sanctioned counterparty faces potential OFAC liability regardless of intent, and an auditor's risk assessment process should reflect that.
The stablecoin accounting dimension
The migration from Bitcoin to USDT on TRON has a direct accounting consequence. USDT is a stablecoin, and its treatment under US GAAP differs from volatile crypto assets. However, the compliance risk attached to specific USDT flows does not disappear because the asset is dollar-pegged. Firms maintaining digital asset accounting software that tracks stablecoin movements need to ensure their transaction monitoring is integrated with sanctions screening, not siloed from it. A stablecoin balance that looks clean on the books may carry embedded counterparty risk if the originating addresses are linked to sanctioned vendors.
What Compliance Teams Should Do Now
TRM's report is explicit that this is a screening problem that is growing, not stabilising. Chinese chemical vendors have found a new retail revenue stream in peptides that coexists with, and financially supports, their fentanyl precursor operations. Several practical steps follow from the findings.
Expand stablecoin screening coverage
If your transaction monitoring currently focuses on Bitcoin or Ethereum address clusters, the shift to USDT on TRON documented by TRM means your screening has a structural gap. Address lists associated with sanctioned Chinese chemical firms, and clusters identified in enforcement actions, should be incorporated into TRON-based stablecoin monitoring as a priority.
Apply heightened scrutiny to consumer-app originating flows
The data shows that US retail buyers are using consumer crypto payment applications rather than exchange accounts. For platforms that sit downstream from these apps and receive USDT or other stablecoin transfers, understanding the originating platform's own AML standards is part of the correspondent-style due diligence framework that regulators increasingly expect.
Review client exposure in relevant sectors
Accounting firms and CFOs serving clients in chemicals, pharmaceuticals, dietary supplements, or fitness should specifically ask whether those clients source inputs or make payments to Chinese counterparties using cryptocurrency. The TRM data establishes that this is not a remote hypothetical: over 150 such vendors accept crypto, and the combined vendor category received USD 37.3 million in 2025 alone.
Document the basis for any no-action decision
Where a compliance review concludes that a particular flow or counterparty does not require a SAR filing or enhanced due diligence, that conclusion should be documented contemporaneously, including the data sources and reasoning applied. Given the pace at which the DOJ and OFAC have been adding Chinese chemical firms to sanctions lists and indictments, a vendor that was unlisted at the time of a transaction may be designated shortly afterward. Good documentation protects the firm and demonstrates a good-faith compliance process.
Frequently Asked Questions
Are grey-market peptide purchases illegal in the US?
The legal status is nuanced. Many peptide compounds are not FDA-approved for human use, making their sale for human consumption a potential violation of the Federal Food, Drug, and Cosmetic Act. Purchasing them is not straightforwardly criminalised at the federal level, but the transaction may still carry legal risk, and, as TRM's data shows, it may indirectly fund sanctioned entities, which creates separate exposure under OFAC rules.
Why does it matter that payments have moved from Bitcoin to USDT on TRON?
It matters because many compliance systems were built around Bitcoin address screening. USDT on TRON operates on a different blockchain with different address formats and different tracing tools. A firm that has not updated its monitoring to cover TRON-based stablecoins has a blind spot that these vendors are actively exploiting.
Does an accounting firm have AML obligations if a client makes these payments?
It depends on the jurisdiction and the firm's registration status, but generally yes. In the US, certain financial professionals and firms have SAR filing obligations. Beyond statutory requirements, professional body guidance from bodies such as the AICPA increasingly expects practitioners to identify and consider financial crime risk during engagements. Sanctions exposure is a separate issue: facilitating a payment to a designated entity can trigger OFAC liability for intermediaries regardless of whether a formal SAR obligation exists.
How should a VASP handle a transaction to an address linked to a sanctioned Chinese chemical vendor?
The transaction should be blocked, the funds should not be released, and the platform should file a SAR with FinCEN and notify OFAC as required under its sanctions compliance programme. The platform should also review whether other historical transactions have involved the same cluster and assess whether a broader look-back is warranted.
What makes this different from other illicit crypto flow typologies?
The retail dimension is distinctive. Most high-profile crypto AML cases involve large transfers between sophisticated actors. Here, the flows are disaggregated across thousands of small consumer purchases, many arriving through mainstream payment apps. That makes aggregate detection harder and places compliance responsibility on a wider range of platforms than a typical typology involving darknet markets or large institutional transfers.
Source: TRM Labs